Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44,064 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety.
Lee M, Je IG, Kim JE, Yoo Y, Lim JH, Jang E, Lee Y, Song DK, Moon AN, Kim JA, Jeong J, Park JT, Lee JW, Yang JH, Hong CH, Park SY, Park YW, Baek NS, Lee S, Ha KS, Choi S, Lee WS. Lee M, et al. Among authors: lee y, lee jw, lee ws, lee s. Mol Cancer Ther. 2023 Mar 2;22(3):333-342. doi: 10.1158/1535-7163.MCT-22-0068. Mol Cancer Ther. 2023. PMID: 36808277 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 36805732
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects.
Kim HC, Yang E, Lee S, Oh J, Lee M, Lee C, Ha KS, Lee WS, Jang IJ, Yu KS. Kim HC, et al. Among authors: lee m, lee ws, lee s, lee c. Invest New Drugs. 2024 Feb;42(1):80-88. doi: 10.1007/s10637-023-01405-z. Epub 2023 Dec 15. Invest New Drugs. 2024. PMID: 38099989 Free PMC article. Clinical Trial.
44,064 results
You have reached the last available page of results. Please see the User Guide for more information.